Target intelligence / Profile preview

Collagen type VI alpha 1 chain (COL6A1)

Target
COL6A1
Molecular classification
Extracellular matrix protein, Structural protein, Collagen family
01

Overview

Collagen type VI alpha 1 chain (COL6A1) encodes the α1 subunit of collagen VI, an essential extracellular matrix protein that assembles into a microfibrillar network to maintain tissue structural integrity and regulate cell–matrix interactions. Type VI collagen is especially important in skeletal muscle, cartilage, tendon, bone, and basement membranes, where it provides mechanical support, links basement membranes to cells, and contributes to cytoprotective pathways (modulating apoptosis, autophagy, and stem cell renewal). Defects in COL6A1 cause a spectrum of muscle and connective tissue diseases, most prominently Bethlem myopathy and Ullrich congenital muscular dystrophy, by disrupting microfibril assembly and cell–matrix signaling. COL6A1 serves as a diagnostic marker for certain myopathies and is under investigation as a therapeutic target and biomarker for tissue engineering and regenerative medicine.

Other names
Collagen alpha-1(VI) chainCOL6A1BTHLM1BTHLM1AOPLLUCHMD1UCHMD1AEpididymis secretory sperm binding proteinCollagen VI, alpha-1 polypeptideCollagen, type VI, alpha 1
02

Mechanism of action

Potential drugs may act by regulating autophagy or stabilizing extracellular matrix interactions. Modulation of apoptotic and mechanotransductive signaling in muscle fibers.

03

Biological functions

Structural integrity of tissuesMechanical strength and elasticity in muscles, tendons, cartilage, bone, and basement membranesCytoprotective effects (protects against apoptosis and oxidative damage)Regulation of autophagy and cell survivalCell–matrix and mechanotransduction signalingMaintenance of stem cell niche and cell differentiation
04

Disease associations

Muscular dystrophies (including Bethlem myopathy and Ullrich congenital muscular dystrophy)Bone disorders (osteoporosis, abnormal bone formation)Joint disease (osteoarthritis, contractures)Tumor growth (some evidence for role in cancer modulation)Possibly neurodegenerative processes (preliminary evidence; see cytoprotective and stemness roles)
05

Safety considerations

Targeting ECM proteins carries risks of impaired tissue integrity, delayed healing, and off-target effects in multiple organsTherapeutic gene editing or inhibition may cause muscle weakness or exacerbate connective tissue disorders
06

Interacting drugs

No direct FDA-approved drugs target COL6A1; however, experimental therapeutic efforts (e.g., agents modulating autophagy such as rapamycin in muscular dystrophy models) have been investigated
07

Biomarkers

COL6A1 mutation screening for diagnosis and prognosis in muscular dystrophiesProtein expression levels in tissue or fluid (muscle biopsy, ECM assessment)

Beyond the preview

Go deeper on Collagen type VI alpha 1 chain (COL6A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type VI alpha 1 chain (COL6A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call